Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion type Assertion NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_head.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion description "[TIL in bladder cancers could be labeled with a specific anti-VEGF mAb, indicating that TIL are likely to be able to secrete VEGF protein in situ at bioactive concentrations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_provenance.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion evidence source_evidence_literature NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_provenance.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion SIO_000772 7545086 NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_provenance.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion wasDerivedFrom befree-20140225 NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_provenance.
- NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_assertion wasGeneratedBy ECO_0000203 NP485772.RAObW6AmTqyPcrqb4inbOrvzZnMVGPmLj7UmjNXijXzW0130_provenance.